Share buybacks · 2023–2025
GSK share buybacks
$1.8B+$1.8B · FY2025
GSK (GSK) reported $1.8B in share buybacks for fiscal 2025, +$1.8B from the year before.
Share buybacks — Share buybacks are the cash a company spent during the year repurchasing its own stock, taken from the financing section of the cash-flow statement. Most companies buy back nothing at all — the line is absent rather than zero — so this ranking covers the minority that do.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Figures are reported under IFRS in GBP and converted to US dollars at ECB reference rates — fiscal 2025 average 0.758 GBP/$ for income items, year-end 0.743 GBP/$ for balance-sheet items.
Share buybacks at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=GSK share buybacks |url=https://companiesranked.com/en/company/gsk/share-buybacks |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). GSK share buybacks. CompaniesRanked. https://companiesranked.com/en/company/gsk/share-buybacksBibTeX
@misc{companiesranked-en-company-gsk-share-buybacks-2026,
author = {{CompaniesRanked}},
title = {{GSK share buybacks}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/gsk/share-buybacks}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001131399-26-000004 · March 6, 2026
{{cite web |title=GSK share buybacks — 20-F (0001131399-26-000004) |url=https://www.sec.gov/Archives/edgar/data/1131399/000113139926000004/gsk-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-06}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.